Min-Ho Kim Lab

From OpenWetWare
Jump to navigationJump to search

Home        Lab Members        Publications        Research               Contact        News       

Welcome to the Kim's research group at Kent State University

The major focus of research interests in our laboratory is to develop nanomedicine strategies towards the treatment of various diseases such as bacterial infections, chronic wounds, and neurological disorders. Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease, which involves the use of nanoscale materials,such as biocompatible nanoparticles. My laboratory develops or utilizes various types of nanoparticles by means of harnessing their unique physicochemical properties for the purpose of either directly targeting pathogens such as multidrug-resistant bacteria, disrupting misfolded proteins such as amyloid plaques, or modifying pro-inflammatory environment of diseased tissue towards an anti-inflammatory and tissue regenerative environment.

Prospective Students

A prospective graduate student (PhD program in Biological Sciences): We are seeking a highly motivated graduate student who is interested in participating to a NIH-funded project for developing therapeutics for Alzheimer’s disease. In this project, a student will engage in a study to understand the pathophysiological mechanism for microglia-mediated clearance of beta-amyloid plaques. A prospective student who is interested in either neuroscience or immunology should send a CV and a brief statement of research interest to mkim15@kent.edu.

Featured News

  • May 2022, Kim lab is awarded with a NIH R01 grant from NIA for investigating magneto-thermal brain stimulation towards the rescue of beta-amyloid pathology, as a potential therapeutic for Alzheimer's disease.[Link her for more info]
  • February 2021, Kim lab's research on the development of new synthetic antimicrobial compound to overcome the development of drug resistance is featured [Link here for more info]
  • January 2021, Kim lab is awarded with a Brain Health Research Institute (BHRI) pilot grant to validate mild magnetic nanoparticle hyperthermia as a strategy to target amyloid beta plaques in animal model of Alzheimer's disease.
  • November 2020, Kim lab is awarded with TeCK Fund grant to develop topical antimicrobial creams towards the treatment of skin and soft tissue MRSA infections.
  • September 2018, Kim lab is awarded with a new NIH supplement grant to pursue a project to develop targeted magnetic nanoparticle hyperthermia that can target amyloid beta plaques towards the treatment of Alzheimer's disease.
  • April 2015, Kim lab is awarded with a NIH R01 grant from NINR to pursue a project to develop non-invasive magnetic nanothermotherapy platform for the treatment of wound biofilm infection.[Link here for more info]